fbpx

Weight Loss

Tirzepatide beats Wegovy?

Mounjaro Tirzepatide Diabetes 2 and Weight Loss

Will Mounjaro Tirzepatide (a new diebetic drug) outdo Wegovy and Saxenda for weight loss in 2023? Many argue it will as research studies show weight loss was even greater among individuals injected with Tirzaptide during a diabeties clinical trial. This newly FDA-approved diabetes medication is being studied as a potential weight-loss power drug. Early research is more than just positive!

Mounjaro Tirzepatide Diabetes 2 and Weight Loss Read More »

en_USEN
Scroll to Top